Asenapine Sublingual Tablets are indicated for
- Bipolar I disorder
- Adjunctive treatment to lithium or valproate in adults
![Asenapine Sublingual Tablets](/sites/default/files/2020-12/Asenapine.jpg)
-
Compare toSaphris®*
Inactive Ingredients
Copovidone, crospovidone, polyoxyl 35 castor oil, mannitol, magnesium stearate, citric acid, butylated hydroxytoluene, silicon dioxide, sodium bicarbonate and black cherry flavor.
*Saphris® is a registered trademark of Allergan.
![Asenapine Sublingual Tablets](/sites/default/files/2020-12/Asenapine.jpg)
Asenapine Sublingual Tablets (5 mg)
-
Package size60 ct
-
Strength5 mg
-
NDC Code42794-0016-10
![Asenapine Sublingual Tablets (5 mg)](/sites/default/files/2021-06/Asenapine-5-mg-1.jpg)
Asenapine Sublingual Tablets (10 mg)
-
Package size60 ct
-
Strength10 mg
-
NDC Code42794-0017-10
![Asenapine Sublingual Tablets (10 mg)](/sites/default/files/2021-06/Asenapine-10-mg-1.jpg)